Grown Rogue International (GRUSF) Prepaid Assets (2011 - 2026)
Grown Rogue International's (GRUSF) quarterly Prepaid Assets came in at $516553.0 in Q1 2026, down 42.07% year-on-year from $891669.8 in Q1 2025, and down 8.4% quarter-over-quarter from $563912.0 in Q4 2025.
Grown Rogue International (GRUSF) Prepaid Assets (2011 - 2026) Analysis & Trends
Grown Rogue International's Prepaid Assets history runs 15 years deep, the most recent figure standing at $516553.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 42.07% year-over-year to $516553.0 in Q1 2026; TTM through Mar 2026 was $516553.0, a 42.07% decrease from a year earlier, with the FY2025 full-year figure at $563912.0, down 19.37% from the prior year.
- Prepaid Assets declined to $516553.0 in Q1 2026 per GRUSF's latest filing, from $563912.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $711.5 billion in Q3 2025 and bottomed at -$29878.1 in Q4 2023.
- The 5-year median for Prepaid Assets is $521124.5 (2024), against an average of $50.8 billion.
- Across the five-year window, Prepaid Assets plunged 853.45% in 2023 and surged 135343125.23% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $3965.5 in 2022, then slumped by 610.29% to -$20235.7 in 2023, then jumped by 3156.48% to $618500.1 in 2024, then retreated by 8.83% to $563912.0 in 2025, then decreased by 8.4% to $516553.0 in 2026.
- Per Business Quant, the three latest GRUSF Prepaid Assets figures stand at $516553.0 (Q1 2026), $563912.0 (Q4 2025), and $711.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 516,553.00 |
| Dec 31, 2025 | 563,912.00 |
| Sep 30, 2025 | 711.49 Bn |
| Jun 30, 2025 | 826,180.00 |
| Mar 31, 2025 | 891,669.79 |
| Dec 31, 2024 | 618,500.10 |
| Sep 30, 2024 | 525,696.06 |
| Jun 30, 2024 | 385,996.15 |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | -20,235.72 |
| Oct 31, 2023 | -29,878.09 |
| Apr 30, 2023 | 343,364.00 |
| Jan 31, 2023 | 362,345.00 |
| Oct 31, 2022 | 3,965.50 |
| Oct 31, 2021 | -156,113.41 |
| Apr 30, 2021 | 275,549.00 |
| Jan 31, 2021 | 79,060.00 |
| Oct 31, 2020 | 14,158.00 |
| Jul 31, 2020 | 62,129.00 |
| Apr 30, 2020 | 82,053.00 |